| Bioactivity | 6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside |
| CAS | 1612191-90-8 |
| Formula | C14H13FN4O3S |
| Molar Mass | 336.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside
CAS: 1612191-90-8 F: C14H13FN4O3S W: 336.34
6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside is a purine nucleoside analogue. Purine nucleoside analogs
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.